Received Apr 2, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Vomiting; Fatigue; Swollen lymph nodes; This non-serious case was reported by a consumer via call center representative and described the occurrence of vomiting in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vomiting (Verbatim: Vomiting), fatigue (Verbatim: Fatigue) and swollen lymph nodes (Verbatim: Swollen lymph nodes). The outcome of the vomiting was resolved (duration 2 days) and the outcome of the fatigue and swollen lymph nodes were resolved (duration 6 weeks). It was unknown if the reporter considered the vomiting, fatigue and swollen lymph nodes to be related to Shingrix. It was unknown if the company considered the vomiting, fatigue and swollen lymph nodes to be related to Shingrix. Additional Information: GSK Receipt Date: 27-MAR-2026 The batch number was not provided and a request for this information has been made.